ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 30 filers reported holding ANNOVIS BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,900 | -33.6% | 10,000 | 0.0% | 0.00% | -40.0% |
| Q2 2023 | $142,900 | -7.3% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $154,100 | +14.7% | 10,000 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $134,300 | -2.0% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $137,000 | +21.2% | 10,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $113,000 | -15.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $134,000 | -23.9% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $176,000 | -65.8% | 10,000 | -38.3% | 0.01% | -68.8% |
| Q3 2021 | $514,000 | -62.5% | 16,200 | +1.2% | 0.02% | -61.0% |
| Q2 2021 | $1,369,000 | +390.7% | 16,000 | +60.0% | 0.04% | +355.6% |
| Q1 2021 | $279,000 | +272.0% | 10,000 | 0.0% | 0.01% | +350.0% |
| Q4 2020 | $75,000 | +56.2% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $48,000 | +9.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $44,000 | +46.7% | 10,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $30,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wescott Financial Advisory Group, LLC | 41,607 | $1,321,000 | 0.75% |
| AIGH Capital Management LLC | 66,469 | $2,110,000 | 0.44% |
| Worth Venture Partners, LLC | 19,878 | $631,000 | 0.28% |
| Knoll Capital Management, LLC | 14,210 | $451,000 | 0.22% |
| Sterling Investment Advisors, Ltd. | 14,474 | $460,000 | 0.14% |
| Essex LLC | 11,962 | $380,000 | 0.10% |
| Redmond Asset Management, LLC | 7,878 | $250,000 | 0.08% |
| Modera Wealth Management, LLC | 33,298 | $1,057,000 | 0.05% |
| Virtus ETF Advisers LLC | 2,387 | $76,000 | 0.03% |
| Virtu Financial LLC | 11,547 | $367,000 | 0.03% |